- Home
- Publications
- Publication Search
- Publication Details
Title
FGF19 and FGF21: In NASH we trust
Authors
Keywords
FGF21, FGF19, NASH, Metabolism, Drug development, Clinical trials
Journal
Molecular Metabolism
Volume -, Issue -, Pages 101152
Publisher
Elsevier BV
Online
2020-12-29
DOI
10.1016/j.molmet.2020.101152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cirrhosis as new indication for statins
- (2020) Jaime Bosch et al. GUT
- The Effects of B1344, a Novel Fibroblast Growth Factor 21 Analog, on Nonalcoholic Steatohepatitis in Nonhuman Primates
- (2020) Aoyuan Cui et al. DIABETES
- FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake
- (2020) Sharon O. Jensen-Cody et al. Cell Metabolism
- Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
- (2020) Kalliopi Pafili et al. Molecular Metabolism
- A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
- (2019) Steven A. Kliewer et al. Cell Metabolism
- Direct and Indirect Effects of FGF15 and FGF19 on Liver Fibrosis Development
- (2019) J D Schumacher et al. HEPATOLOGY
- FGF21 gene therapy as treatment for obesity and insulin resistance
- (2018) Veronica Jimenez et al. EMBO Molecular Medicine
- FGF21 acts as a negative regulator of bile acid synthesis
- (2018) Michelle M Chen et al. JOURNAL OF ENDOCRINOLOGY
- Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
- (2018) Yan Weng et al. Scientific Reports
- Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
- (2018) Archita Agrawal et al. Molecular Metabolism
- Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in db/db mice
- (2018) Ann Maria K. Hansen et al. BIOCHEMICAL JOURNAL
- Fibroblast Growth Factor 15/19 – From Basic Functions to Therapeutic Perspectives
- (2018) Emmanuel Somm et al. ENDOCRINE REVIEWS
- Structures of β-klotho reveal a ‘zip code’-like mechanism for endocrine FGF signalling
- (2018) Sangwon Lee et al. NATURE
- Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis
- (2018) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study
- (2018) Edgar D. Charles et al. Obesity
- A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys
- (2017) Shanaka Stanislaus et al. ENDOCRINOLOGY
- Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
- (2017) Mei Zhou et al. JOURNAL OF HEPATOLOGY
- Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
- (2017) Mei Zhou et al. Nature Communications
- A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism
- (2017) ffolliott M. Fisher et al. Molecular Metabolism
- FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis
- (2017) Emilio P. Mottillo et al. Molecular Metabolism
- FGF21 Regulates Sweet and Alcohol Preference
- (2016) Saswata Talukdar et al. Cell Metabolism
- A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
- (2016) Saswata Talukdar et al. Cell Metabolism
- FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
- (2016) Christian Schlein et al. Cell Metabolism
- FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver
- (2016) Stephanie von Holstein-Rathlou et al. Cell Metabolism
- Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity
- (2016) Ricardo J. Samms et al. ENDOCRINOLOGY
- The Nuclear Receptor Rev-erbα Regulates Adipose Tissue-specific FGF21 Signaling
- (2016) Jennifer Jager et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21
- (2016) Diana Ronai Dunshee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists
- (2016) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
- (2016) W. Clayton Thompson et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways
- (2016) Pengfei Xu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth Factors
- (2016) Justin D. Schumacher et al. Biomed Research International
- Fibroblast activation protein (FAP) as a novel metabolic target
- (2016) Miguel Angel Sánchez-Garrido et al. Molecular Metabolism
- Human FGF-21 Is a Substrate of Fibroblast Activation Protein
- (2016) Andrew L. Coppage et al. PLoS One
- Circulating FGF21 proteolytic processing mediated by fibroblast activation protein
- (2015) E. Y. Zhen et al. BIOCHEMICAL JOURNAL
- Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study
- (2015) Jennifer Q. Dong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- FGF21 and the late adaptive response to starvation in humans
- (2015) Pouneh K. Fazeli et al. JOURNAL OF CLINICAL INVESTIGATION
- Protein-dependent regulation of feeding and metabolism
- (2015) Christopher D. Morrison et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties
- (2015) Alexei Kharitonenkov et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance
- (2015) Barbara Bernardo et al. Scientific Reports
- Fructose ingestion acutely stimulates circulating FGF21 levels in humans
- (2015) Jody R. Dushay et al. Molecular Metabolism
- Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice
- (2015) Yan Weng et al. PLoS One
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
- (2014) Bryn M. Owen et al. Cell Metabolism
- Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
- (2014) K. R. Markan et al. DIABETES
- A nontumorigenic variant of FGF19 treats cholestatic liver diseases
- (2014) J. Luo et al. Science Translational Medicine
- Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake
- (2013) Toshiko Tanaka et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
- (2013) Zhuofeng Lin et al. Cell Metabolism
- An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
- (2013) William L. Holland et al. Cell Metabolism
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
- (2013) K. M. Habegger et al. DIABETES
- Fibroblast Growth Factor 21 Improves Insulin Resistance and Ameliorates Renal Injury indb/dbMice
- (2013) H. W. Kim et al. ENDOCRINOLOGY
- Novel locus including FGF21 is associated with dietary macronutrient intake
- (2013) Audrey Y. Chu et al. HUMAN MOLECULAR GENETICS
- FGF19 action in the brain induces insulin-independent glucose lowering
- (2013) Gregory J. Morton et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF21 regulates metabolism and circadian behavior by acting on the nervous system
- (2013) Angie L Bookout et al. NATURE MEDICINE
- Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
- (2013) Alexei Kharitonenkov et al. PLoS One
- LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
- (2013) Andrew C. Adams et al. PLoS One
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
- (2012) Xunshan Ding et al. Cell Metabolism
- Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys
- (2012) Murielle M. Véniant et al. ENDOCRINOLOGY
- TNF-α Represses β-Klotho Expression and Impairs FGF21 Action in Adipose Cells: Involvement of JNK1 in the FGF21 Pathway
- (2012) Julieta Díaz-Delfín et al. ENDOCRINOLOGY
- Fibroblast Growth Factor-19 Action in the Brain Reduces Food Intake and Body Weight and Improves Glucose Tolerance in Male Rats
- (2012) Karen K. Ryan et al. ENDOCRINOLOGY
- Characterization of a FGF19 Variant with Altered Receptor Specificity Revealed a Central Role for FGFR1c in the Regulation of Glucose Metabolism
- (2012) Hongfei Ge et al. PLoS One
- Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
- (2012) Andrew C. Adams et al. PLoS One
- FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
- (2012) Murielle M. Véniant et al. PLoS One
- FGF21 Requires βklotho to Act In Vivo
- (2012) Andrew C. Adams et al. PLoS One
- Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor
- (2012) W. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the Klotho/FGFR1c Receptor Complex
- (2012) I. N. Foltz et al. Science Translational Medicine
- The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue
- (2012) Andrew C. Adams et al. Molecular Metabolism
- Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
- (2010) D. A. Sarruf et al. DIABETES
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
- (2010) Klementina Fon Tacer et al. MOLECULAR ENDOCRINOLOGY
- Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)
- (2010) X. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast growth factor 21: from pharmacology to physiology
- (2009) Steven A Kliewer et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects
- (2009) Jing Xu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
- (2009) Xinle Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Different roles of N- and C- termini in the functional activity of FGF21
- (2009) Radmila Micanovic et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Glycosaminoglycan affinity of the complete fibroblast growth factor family
- (2008) Masahiro Asada et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man
- (2008) Cecilia Gälman et al. Cell Metabolism
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Serum Levels of the Adipokine FGF21 Depend on Renal Function
- (2008) S. Stein et al. DIABETES CARE
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- FGF21 N- and C-termini play different roles in receptor interaction and activation
- (2008) Junming Yie et al. FEBS LETTERS
- FGF21 is an Akt-regulated myokine
- (2008) Yasuhiro Izumiya et al. FEBS LETTERS
- FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
- (2007) Alexei Kharitonenkov et al. JOURNAL OF CELLULAR PHYSIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started